Journals

This article describes a recently initiated Phase II trial of a novel anti-tau monoclonal antibody, BMS-986446, the design for which was…

We are delighted to announce the release of the latest EMJ Innovations journal! Inside you will find a diverse variety of content…

In this symposium, three case studies from the UK and Spain demonstrated how fewer appointments per patient with faricimab resulted in…

A satellite symposium titled ‘Transforming MS Care: Early Intervention and Sustained Safety’ held at the 40th Congress of the European…

Great advances have been made in the field of generalised myasthenia gravis (gMG) in recent years; however, many patients remain…

As the global population of adults aged over 60 years increases rapidly, the burden of infectious respiratory diseases such as COVID-19…

Smoking is a major risk factor for cardiovascular disease (CVD) and responsible for around 25% of all CVD-related deaths worldwide…

Featuring a range of content spanning multiple therapeutic areas, with a focus on women’s health, we explore several key topics…